Showing 3201-3210 of 10618 results for "".
The Best System that Money Can Buy
https://reachmd.com/programs/clinicians-roundtable/the-best-system-that-money-can-buy/3159/Our guest, David Johnson, managing director of Citi’s industry leading health care group addresses the potential of outsourcing patients across borders at great savings. This may make us realize that when our president in 1993 stated that the "system was broken and it was time to fix it "may have beBridges To Excellence: Physician Office Link
https://reachmd.com/programs/clinicians-roundtable/bridges-to-excellence-physician-office-link/2806/Bridges to Excellence (BTE) is a national not-for-profit organization that designs and implements programs to recognize and reward physicians that deliver high quality care. In talking with BTE’s CEO, Francios de Brantes, host Dr. Bill Rutenberg learns about BTE’s methodology for measuring quality,Doctors:Unwilling Pawns in Healthcare Finance Game
https://reachmd.com/programs/revealing-retina/doctorsunwilling-pawns-in-healthcare-finance-game/2772/Dr. Roy Levit welcomes Dr. Michael Newton, Medical Ethicist and an Ophthalmologist specializing in corneal disease and transplantation. They will dicuss Dr. Newton's book, "Without Your Consent, The Hijacking of American Health Care". They will cover all of the outside influences from managed care tHope: A Complement to Cancer Treatment
https://reachmd.com/programs/clinicians-roundtable/hope-a-complement-to-cancer-treatment/2756/When it comes to cancer care, we know about chemotherapy, surgery, bone marrow transplants and even the coming of stem cell therapies. But should hope also be included as a treatment for these life threatening diseases? Dr. Edgar Staren, senior vice president for clinical affairs and chief medical oWhy We'll Never Cure Cancer?
https://reachmd.com/programs/clinicians-roundtable/why-well-never-cure-cancer/2389/What is keeping our society from moving forward in our ability to cure disease? How can what is learned in the lab be brought to the frontlines more quickly and efficiently? How can individual medical institutions work together to make a more profound difference in our healthcare system? Our GuestBiology of Embryonic Stem Cells
https://reachmd.com/programs/clinicians-roundtable/biology-of-embryonic-stem-cells/2251/John A. Kessler MD, Davee Professor of Stem Cell Biology, Chairman, Davee Department of Neurology, Northwestern University Medical School in Chicago. Dr. Kessler is one of the world’s leaders in stem cell research to repair central and peripheral nerve damage. He joins us to talk about the biologyDiagnosing and Treating CF: What is new?
https://reachmd.com/programs/clinicians-roundtable/diagnosing-and-treating-cf-what-is-new/2099/Our guest Dr. Rick Moss discuses with host, Dr. Bill Rutenberg current modes of diagnosis, including the genetic basis of CF. This is followed by a discussion of current and future treatments for cystic fibrosis, including lung transplantation, stem cell and gene therapies.Emergency Department-Scope of Practice
https://reachmd.com/programs/clinicians-roundtable/emergency-department-scope-of-practice/395/Dr. William Maloney, Chair of the Department of Emergency Medicine at Condell Medical Center, discusses the level of expertise needed for the diverse scope of care required in the ED today.Ergonomic Strategies for Successful Hair Transplant Procedures
https://reachmd.com/programs/dermconsult/ergonomic-strategies-hair-transplant-procedure/49025/Lengthy hair transplant procedures place significant physical demands on patients, physicians, and staff, making ergonomics a critical part of success. Dr. Marc Avram outlines practical, real-world strategies to improve positioning, workflow, and the procedural environment to enhance comfortParkinson’s Research in Focus: Translating Science Into Clinical Progress
https://reachmd.com/programs/neurofrontiers/parkinsons-research-clinical-progress/48727/Translational research is reshaping the way we understand, detect, and manage Parkinson’s disease. To learn more about how current research efforts are uncovering early biomarkers and redefining intervention strategies, Dr. Jerome Lisk sits down with Dr. Michael Salvatore and Dr. Vicki Nejtek-Salvat